Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables
Andrea de Bartolomeis, Emiliano Prinzivalli, Gemma Callovini, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 81, pp. 356-366
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies
Sophie E Smart, Adrianna P. Kępińska, Robin M. Murray, et al.
Psychological Medicine (2019) Vol. 51, Iss. 1, pp. 44-53
Open Access | Times Cited: 68
Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis
Kawtar El Abdellati, Livia De Picker, Manuel Morrens
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 65
Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics
Andrea de Bartolomeis, Licia Vellucci, Mark C. Austin, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 909-909
Open Access | Times Cited: 29
Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis
Edward Millgate, Olga Hide, Stephen M. Lawrie, et al.
Psychological Medicine (2021) Vol. 52, Iss. 1, pp. 1-13
Open Access | Times Cited: 32
Severity of Autism-Related Symptoms in Treatment-Resistant Schizophrenia: Associations with Cognitive Performance, Psychosocial Functioning, and Neurological Soft Signs — Clinical Evidence and ROC Analysis
Licia Vellucci, Annarita Barone, Elisabetta Filomena Buonaguro, et al.
Journal of Psychiatric Research (2025)
Open Access
Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
Marina Šagud, Lucija Tudor, Suzana Uzun, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 33
Relationships between early age at onset of psychotic symptoms and treatment resistant schizophrenia
Felice Iasevoli, Eugenio Razzino, Benedetta Altavilla, et al.
Early Intervention in Psychiatry (2021) Vol. 16, Iss. 4, pp. 352-362
Open Access | Times Cited: 27
Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal
Felice Iasevoli, Camilla Avagliano, Luigi D’Ambrosio, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 895-895
Open Access | Times Cited: 10
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs
Felice Iasevoli, Camilla Avagliano, Benedetta Altavilla, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 29
Autistic traits and cognitive profiles of treatment-resistant schizophrenia
Yusuke Nakata, Nobuhisa Kanahara, Atsushi Kimura, et al.
Schizophrenia Research Cognition (2020) Vol. 22, pp. 100186-100186
Open Access | Times Cited: 27
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients
Anna Maio, Arianna De Rosa, Silvia Pelucchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1539-1539
Open Access | Times Cited: 15
Neurological Soft Signs Predict Auditory Verbal Hallucinations in Patients With Schizophrenia
Robert Christian Wolf, Mahmoud Rashidi, Mike M. Schmitgen, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 2, pp. 433-443
Open Access | Times Cited: 22
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach
Annarita Barone, Michele De Prisco, Benedetta Altavilla, et al.
Journal of Psychiatric Research (2022) Vol. 155, pp. 572-578
Closed Access | Times Cited: 14
Patterns of Management of Patients With Dual Disorder (Psychosis) in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical Practice
Massimo Clerici, Andrea de Bartolomeis, Sergio De Filippis, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 19
Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study
Felice Iasevoli, Luigi D’Ambrosio, Mariateresa Ciccarelli, et al.
Schizophrenia Bulletin (2022) Vol. 49, Iss. 2, pp. 474-485
Open Access | Times Cited: 10
Neurological Soft Signs in Schizophrenia, a Picture of the Knowledge in the Last Decade: A Scoping Review
Cristian Petrescu, Diana M. Petrescu, Gabriela Marian, et al.
Healthcare (2023) Vol. 11, Iss. 10, pp. 1471-1471
Open Access | Times Cited: 6
Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients
Felice Iasevoli, Luigi D’Ambrosio, Danilo Notar Francesco, et al.
Schizophrenia Research (2018) Vol. 202, pp. 217-225
Closed Access | Times Cited: 17
Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia
Andrea de Bartolomeis, Camilla Avagliano, Licia Vellucci, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 795-827
Closed Access | Times Cited: 17
Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients
Marta Matrone, Georgios D. Kotzalidis, Andrea Romano, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 114, pp. 110493-110493
Closed Access | Times Cited: 14
Evaluation of a few discrete clinical markers may predict categorization of actively symptomatic non-acute schizophrenia patients as treatment resistant or responders: A study by ROC curve analysis and multivariate analyses
Felice Iasevoli, Camilla Avagliano, Benedetta Altavilla, et al.
Psychiatry Research (2018) Vol. 269, pp. 481-493
Closed Access | Times Cited: 13
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic risk
L. Prohens, Natàlia Rodríguez, Àlex-González Segura, et al.
Psychiatry Research (2024) Vol. 332, pp. 115722-115722
Open Access | Times Cited: 1
Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study
An-Sheng Lin, Hung‐Yu Chan, Ying-Chieh Peng, et al.
BMC Psychiatry (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Different trajectories of neurological soft signs progression between treatment-responsive and treatment-resistant schizophrenia patients
Simon S. Y. Lui, Stanley S. L. Yip, Ya Wang, et al.
Journal of Psychiatric Research (2021) Vol. 138, pp. 607-614
Closed Access | Times Cited: 10
Search for Association of Polymorphisms rs6280 of the DRD3 Gene, rs4680 of the COMT Gene, rs6265 of the Gene BDNF with Schizophrenia Resistant to Antipsychotic Therapy in Russian Populations
M. A. Kaydan, Natalia V. Zakharova, Yana Zorkina, et al.
Psikhiatriya (2024) Vol. 21, Iss. 7, pp. 14-23
Open Access | Times Cited: 1
Neurodevelopmental predictors of treatment response in schizophrenia and bipolar disorder
Anton Iftimovici, Emma Krebs, William Dalfin, et al.
Psychological Medicine (2024) Vol. 54, Iss. 13, pp. 3655-3666
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top